Month: <span>February 2020</span>

Home / 2020 / February
Post

New therapeutic approach may help to cure chronic hepatitis B infection

by Helmholtz Association of German Research Centres Researchers at Helmholtz Zentrum München, Technical University of Munich (TUM) and the German Center for Infection Research (DZIF) have developed a novel therapeutic approach to cure chronic hepatitis B. The scientists found that the large amount of hepatitis B virus proteins expressed in the liver prevents the body’s...

Study shows that hepatitis C drug EPCLUSA has the potential to inhibit coronaviruses
Post

Study shows that hepatitis C drug EPCLUSA has the potential to inhibit coronaviruses

by Columbia University Columbia Engineering researchers have been developing strategies to cope with the new strain of coronavirus, 2019-nCoV, that has caused a global public health emergency. In their latest study, “Nucleotide analogues as inhibitors of viral polymerases,” posted now in bioRxiv, the researchers recognized that the hepatitis C virus and coronaviruses use a similar...

Researchers provide new insights into the pathogenesis of epilepsy
Post

Researchers provide new insights into the pathogenesis of epilepsy

by Foundation For Research and Technology – Hellas, Foundation for Research and Technology – Hellas The laboratories of Drs. Peyman Golshani at the University of California in Los Angeles, Tristan Shuman at Mount Sinai Hospital in New York, and Panayiota Poirazi at the Institute of Molecular Biology & Biotechnology (IMBB) at the Foundation for Research...

New deep learning model can accurately identify sleep stages
Post

New deep learning model can accurately identify sleep stages

UNIVERSITY OF EASTERN FINLAND A new deep learning model developed by researchers at the University of Eastern Finland can identify sleep stages as accurately as an experienced physician. This opens up new avenues for the diagnostics and treatment of sleep disorders, including obstructive sleep apnoea. Obstructive sleep apnoea (OSA) is a nocturnal breathing disorder that...

Study reveals new way to treat stroke using an already FDA-approved drug
Post

Study reveals new way to treat stroke using an already FDA-approved drug

Researchers first to report neuroprotective properties of granulocyte colony-stimulating factor FLORIDA ATLANTIC UNIVERSITY Stroke is the third leading cause of death and disability in the United States. More than 87 percent are ischemic strokes, caused by obstruction of one or more cerebral arteries. With limited progress in developing treatments, there is a critical need for...

Novel compound is promising drug candidate for Alzheimer’s disease
Post

Novel compound is promising drug candidate for Alzheimer’s disease

by Rensselaer Polytechnic Institute A newly identified compound is a promising candidate for inhibiting the production of amyloids, the abnormal proteins that form toxic clumps, called fibrils, inside the brains of patients with Alzheimer’s disease. As published today in the Royal Society of Chemistry’s Chemical Communications, the compound—known as “C1″—uses a novel mechanism to efficiently...

Neurodevelopment team locates a gene that helps control puberty and human reproduction
Post

Neurodevelopment team locates a gene that helps control puberty and human reproduction

by University at Albany Thousands of Americans suffer from the delay or non-appearance of puberty. While the underlying cause is failure in the correct action of the hypothalamic hormone GnRH, the precise genetic causes have not been fully understood. A UAlbany biologist and his research team have now identified a particular gene and its mutation...